{"id":"https://openalex.org/W4304694307","doi":"https://doi.org/10.1158/0008-5472.can-22-0787","title":"Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody\u2013Drug Conjugates in Breast Cancer","display_name":"Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody\u2013Drug Conjugates in Breast Cancer","publication_year":2022,"publication_date":"2022-10-12","ids":{"openalex":"https://openalex.org/W4304694307","doi":"https://doi.org/10.1158/0008-5472.can-22-0787","pmid":"https://pubmed.ncbi.nlm.nih.gov/36222720","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9755966"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-22-0787","doi":"https://doi.org/10.1158/0008-5472.can-22-0787","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-22-0787","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/82/24/4670/3230524/4670.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aacrjournals.org/cancerres/article-pdf/82/24/4670/3230524/4670.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066822780","display_name":"Santiago Duro\u2010S\u00e1nchez","orcid":"https://orcid.org/0000-0002-3829-7562","observed_orcids":["https://orcid.org/0000-0002-3829-7562"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Santiago Duro-S\u00e1nchez","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","3Department of Biochemistry and Molecular Biology, Universitat Aut\u00f3noma de Barcelona, Bellaterra, Spain","4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-3829-7562","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"3Department of Biochemistry and Molecular Biology, Universitat Aut\u00f3noma de Barcelona, Bellaterra, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]},{"raw_affiliation_string":"Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026139001","display_name":"Mercedes Nadal\u2010Serrano","orcid":"https://orcid.org/0000-0002-1299-495X","observed_orcids":["https://orcid.org/0000-0002-1299-495X"]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mercedes Nadal-Serrano","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-1299-495X","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042922994","display_name":"Marta Lalinde-Guti\u00e9rrez","orcid":"https://orcid.org/0000-0002-9858-8775","observed_orcids":["https://orcid.org/0000-0002-9858-8775"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta Lalinde-Guti\u00e9rrez","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","3Department of Biochemistry and Molecular Biology, Universitat Aut\u00f3noma de Barcelona, Bellaterra, Spain","4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-9858-8775","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"3Department of Biochemistry and Molecular Biology, Universitat Aut\u00f3noma de Barcelona, Bellaterra, Spain","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]},{"raw_affiliation_string":"Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024268025","display_name":"Enrique Javier Arenas","orcid":"https://orcid.org/0000-0001-7076-2666","observed_orcids":["https://orcid.org/0000-0001-7076-2666"]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Enrique Javier Arenas","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7076-2666","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014248500","display_name":"Cristina Bernad\u00f3 Morales","orcid":"https://orcid.org/0000-0003-1376-0407","observed_orcids":["https://orcid.org/0000-0003-1376-0407"]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Bernad\u00f3 Morales","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-1376-0407","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086770050","display_name":"Beatriz Morancho","orcid":"https://orcid.org/0000-0003-3369-8647","observed_orcids":["https://orcid.org/0000-0003-3369-8647"]},"institutions":[{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Beatriz Morancho","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-3369-8647","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053053038","display_name":"Marta Escorihuela","orcid":"https://orcid.org/0000-0001-9074-2339","observed_orcids":["https://orcid.org/0000-0001-9074-2339"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Marta Escorihuela","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-9074-2339","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sandra P\u00e9rez-Ramos","orcid":"https://orcid.org/0000-0002-3612-4027","observed_orcids":["https://orcid.org/0000-0002-3612-4027"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sandra P\u00e9rez-Ramos","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-3612-4027","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075766981","display_name":"Santiago Escriv\u00e1-de-Roman\u00ed","orcid":"https://orcid.org/0000-0001-7816-7589","observed_orcids":["https://orcid.org/0000-0001-7816-7589"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Santiago Escriv\u00e1-de-Roman\u00ed","raw_affiliation_strings":["5Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7816-7589","affiliations":[{"raw_affiliation_string":"5Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013496439","display_name":"Luc\u00eda Gandullo\u2010S\u00e1nchez","orcid":"https://orcid.org/0000-0002-7841-230X","observed_orcids":["https://orcid.org/0000-0002-7841-230X"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Luc\u00eda Gandullo-S\u00e1nchez","raw_affiliation_strings":["2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","5Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-7841-230X","affiliations":[{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"5Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]},{"raw_affiliation_string":"Breast Cancer and Melanoma Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641","https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054921200","display_name":"Atanasio Pandiella","orcid":"https://orcid.org/0000-0002-4704-8971","observed_orcids":["https://orcid.org/0000-0002-4704-8971"]},"institutions":[{"id":"https://openalex.org/I4210138819","display_name":"Centro de Investigaci\u00f3n del C\u00e1ncer","ror":"https://ror.org/04rxrdv16","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4210138819"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388891778","display_name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer de Salamanca","ror":"https://ror.org/043vr8e29","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I184999862","https://openalex.org/I4388891778"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Atanasio Pandiella","raw_affiliation_strings":["2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","6Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC, Salamanca, Spain"],"raw_orcid":"https://orcid.org/0000-0002-4704-8971","affiliations":[{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"6Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC, Salamanca, Spain","institution_ids":["https://openalex.org/I4210138819","https://openalex.org/I4388891778"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015120537","display_name":"Anna Esteve\u2010Codina","orcid":"https://orcid.org/0000-0003-0361-2873","observed_orcids":["https://orcid.org/0000-0003-0361-2873"]},"institutions":[{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]},{"id":"https://openalex.org/I4210132884","display_name":"Barcelona Institute of Science and Technology","ror":"https://ror.org/03kpps236","country_code":"ES","type":"education","lineage":["https://openalex.org/I4210132884"]},{"id":"https://openalex.org/I4210137962","display_name":"Centre for Genomic Regulation","ror":"https://ror.org/03wyzt892","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210132884","https://openalex.org/I4210137962","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Anna Esteve-Codina","raw_affiliation_strings":["7NAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain","8Universitat Pompeu Fabra (UPF), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-0361-2873","affiliations":[{"raw_affiliation_string":"7NAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain","institution_ids":["https://openalex.org/I4210132884","https://openalex.org/I4210137962"]},{"raw_affiliation_string":"8Universitat Pompeu Fabra (UPF), Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023945907","display_name":"Ver\u00f3nica Rodilla","orcid":"https://orcid.org/0000-0003-0512-4179","observed_orcids":["https://orcid.org/0000-0003-0512-4179"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ver\u00f3nica Rodilla","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0003-0512-4179","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038119899","display_name":"Fred A. Dijcks","orcid":"https://orcid.org/0000-0002-6023-9422","observed_orcids":["https://orcid.org/0000-0002-6023-9422"]},"institutions":[{"id":"https://openalex.org/I4405267618","display_name":"Byondis BV (Netherlands)","ror":"https://ror.org/03kxd1c72","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405267618"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Fred A. Dijcks","raw_affiliation_strings":["9Byondis B.V., Nijmegen, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-6023-9422","affiliations":[{"raw_affiliation_string":"9Byondis B.V., Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I4405267618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071373994","display_name":"Wim H.A. Dokter","orcid":"https://orcid.org/0000-0002-0181-3877","observed_orcids":["https://orcid.org/0000-0002-0181-3877"]},"institutions":[{"id":"https://openalex.org/I4405267618","display_name":"Byondis BV (Netherlands)","ror":"https://ror.org/03kxd1c72","country_code":"NL","type":"company","lineage":["https://openalex.org/I4405267618"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wim H.A. Dokter","raw_affiliation_strings":["9Byondis B.V., Nijmegen, the Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-0181-3877","affiliations":[{"raw_affiliation_string":"9Byondis B.V., Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I4405267618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-7623-1583","affiliations":[{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082195410","display_name":"Cristina Saura","orcid":"https://orcid.org/0000-0001-8296-5065","observed_orcids":["https://orcid.org/0000-0001-8296-5065"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Cristina Saura","raw_affiliation_strings":["4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0001-8296-5065","affiliations":[{"raw_affiliation_string":"4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077169627","display_name":"Joaqu\u00edn Arribas","orcid":"https://orcid.org/0000-0002-0504-0664","observed_orcids":["https://orcid.org/0000-0002-0504-0664"]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I170486558","display_name":"Universitat Pompeu Fabra","ror":"https://ror.org/04n0g0b29","country_code":"ES","type":"education","lineage":["https://openalex.org/I170486558"]},{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Joaqu\u00edn Arribas","raw_affiliation_strings":["10Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain","1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","8Universitat Pompeu Fabra (UPF), Barcelona, Spain"],"raw_orcid":"https://orcid.org/0000-0002-0504-0664","affiliations":[{"raw_affiliation_string":"10Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain","institution_ids":["https://openalex.org/I11932220"]},{"raw_affiliation_string":"1Preclinical and Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]},{"raw_affiliation_string":"2Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"4Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]},{"raw_affiliation_string":"8Universitat Pompeu Fabra (UPF), Barcelona, Spain","institution_ids":["https://openalex.org/I170486558"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5077169627"],"corresponding_institution_ids":["https://openalex.org/I11932220","https://openalex.org/I170486558","https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109","https://openalex.org/I4210158561","https://openalex.org/I4387155398"],"apc_list":null,"apc_paid":null,"fwci":4.2869,"has_fulltext":true,"cited_by_count":45,"citation_normalized_percentile":{"value":0.96378892,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"82","issue":"24","first_page":"4670","last_page":"4679"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.7728999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.10649999976158142,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/therapy-induced-senescence","display_name":"therapy-induced senescence","score":0.9229999780654907},{"id":"https://openalex.org/keywords/her2-targeted-antibody-drug-conjugates","display_name":"HER2-targeted antibody-drug conjugates","score":0.9390000104904175},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.8379999995231628},{"id":"https://openalex.org/keywords/lysosomal-enlargement","display_name":"lysosomal enlargement","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cathepsin-b","display_name":"cathepsin B","score":0.9670000076293945},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8299999833106995},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.8500000238418579},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8920000195503235}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6111136674880981},{"id":"https://openalex.org/C522857546","wikidata":"https://www.wikidata.org/wiki/Q2070979","display_name":"Senescence","level":2,"score":0.545305073261261},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.5224401354789734},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4874001145362854},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.45288705825805664},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44637829065322876},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.41952115297317505},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4011882543563843},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38505011796951294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36505359411239624},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2686702013015747},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2447723150253296},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1847608983516693},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1308591067790985},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.12968316674232483}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002401","descriptor_name":"Cathepsin B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1158/0008-5472.can-22-0787","doi":"https://doi.org/10.1158/0008-5472.can-22-0787","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-22-0787","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/82/24/4670/3230524/4670.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:36222720","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36222720","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9755966","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9755966/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Res","raw_type":"Text"},{"id":"pmh:oai:ddd.uab.cat:270568","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/270568","pdf_url":null,"source":{"id":"https://openalex.org/S4306400380","display_name":"Dip\u00f2sit Digital de Documents de la UAB (Universitat Aut\u00f2noma de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123044942","host_organization_name":"Universitat Aut\u00f2noma de Barcelona","host_organization_lineage":["https://openalex.org/I123044942"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:digital.csic.es:10261/297162","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10261/297162","pdf_url":null,"source":{"id":"https://openalex.org/S4306400616","display_name":"DIGITAL.CSIC (Spanish National Research Council (CSIC))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I134820265","host_organization_name":"Consejo Superior de Investigaciones Cient\u00edficas","host_organization_lineage":["https://openalex.org/I134820265"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"art\u00edculo"},{"id":"pmh:oai:repositori.upf.edu:10230/55373","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10230/55373","pdf_url":null,"source":{"id":"https://openalex.org/S4306402615","display_name":"Repositori digital de la UPF (Universitat Pompeu Fabra)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I170486558","host_organization_name":"Universitat Pompeu Fabra","host_organization_lineage":["https://openalex.org/I170486558"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-22-0787","doi":"https://doi.org/10.1158/0008-5472.can-22-0787","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-22-0787","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/82/24/4670/3230524/4670.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9886999726295471,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G181761721","display_name":null,"funder_award_id":"CB16/12/00449","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G2980705838","display_name":"Inmunoterapia contra tumores HER2 positivos","funder_award_id":"PI19/01181","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G4637971521","display_name":null,"funder_award_id":"PT17/0009/0019","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G5063179782","display_name":null,"funder_award_id":"BCRF-20-008","funder_id":"https://openalex.org/F4320306260","funder_display_name":"Breast Cancer Research Foundation"},{"id":"https://openalex.org/G6372613876","display_name":null,"funder_award_id":"AC15/00062","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"},{"id":"https://openalex.org/G6825065630","display_name":null,"funder_award_id":"ERA-NET TRANSCAN-2","funder_id":"https://openalex.org/F4320332999","funder_display_name":"Horizon 2020 Framework Programme"},{"id":"https://openalex.org/G8444338040","display_name":null,"funder_award_id":"CB16/12/00449 and PI19/01181","funder_id":"https://openalex.org/F4320334923","funder_display_name":"Instituto de Salud Carlos III"}],"funders":[{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320310220","display_name":"Fundaci\u00f3n Mutua Madrile\u00f1a","ror":"https://ror.org/00skv9577"},{"id":"https://openalex.org/F4320315062","display_name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","ror":null},{"id":"https://openalex.org/F4320321411","display_name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","ror":"https://ror.org/00gxct719"},{"id":"https://openalex.org/F4320332999","display_name":"Horizon 2020 Framework Programme","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F7296444849","display_name":"Ministerio de Universidades","ror":"https://ror.org/03zcny908"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4304694307.pdf","grobid_xml":"https://content.openalex.org/works/W4304694307.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W801307095","https://openalex.org/W1538904872","https://openalex.org/W1971738718","https://openalex.org/W1982481909","https://openalex.org/W1984007340","https://openalex.org/W1995205742","https://openalex.org/W2077499130","https://openalex.org/W2090057677","https://openalex.org/W2104908670","https://openalex.org/W2113844650","https://openalex.org/W2122804955","https://openalex.org/W2127433418","https://openalex.org/W2137763083","https://openalex.org/W2149441684","https://openalex.org/W2164719183","https://openalex.org/W2188229458","https://openalex.org/W2678824027","https://openalex.org/W2729267899","https://openalex.org/W2766999483","https://openalex.org/W2884253843","https://openalex.org/W2888744210","https://openalex.org/W2916664436","https://openalex.org/W2978160779","https://openalex.org/W2981220896","https://openalex.org/W2988310131","https://openalex.org/W2996630100","https://openalex.org/W3005585857","https://openalex.org/W3011656223","https://openalex.org/W3018222852","https://openalex.org/W3029435888","https://openalex.org/W3088158882","https://openalex.org/W3201269418","https://openalex.org/W3201868138","https://openalex.org/W3203425221","https://openalex.org/W4255072072"],"related_works":["https://openalex.org/W7152732563","https://openalex.org/W7149008638","https://openalex.org/W3198102288","https://openalex.org/W2137763083","https://openalex.org/W7095803903","https://openalex.org/W4415444406","https://openalex.org/W4391882108","https://openalex.org/W3083446993","https://openalex.org/W3042224347","https://openalex.org/W4415444365"],"abstract_inverted_index":{"Antibody-drug":[0],"conjugates":[1],"(ADC)":[2],"are":[3,58],"antineoplastic":[4],"agents":[5,65],"recently":[6],"introduced":[7],"into":[8],"the":[9,23,86,89,93,96,99,114,121,145,153,169,175,210],"antitumor":[10,61,201],"arsenal.":[11],"T-DM1,":[12],"a":[13,50,72,191,249],"trastuzumab-based":[14],"ADC":[15],"that":[16,107,109,180,238],"relies":[17],"on":[18,150],"lysosomal":[19,44,90,129],"processing":[20],"to":[21,98],"release":[22],"payload,":[24],"is":[25,85],"approved":[26],"for":[27,221],"HER2-positive":[28,233],"breast":[29,135,187,234],"cancer.":[30],"Next-generation":[31],"ADCs":[32,149,215,231],"targeting":[33,216],"HER2,":[34],"such":[35],"as":[36],"[vic-]trastuzumab":[37],"duocarmazine":[38],"(SYD985),":[39],"bear":[40],"linkers":[41],"cleavable":[42],"by":[43,53,76,247],"proteases":[45],"and":[46,125,131,197,225],"membrane-permeable":[47],"drugs,":[48],"mediating":[49],"bystander":[51,154,177,250],"effect":[52,147,155,251],"which":[54],"neighboring":[55],"antigen-negative":[56,253],"cells":[57,160],"eliminated.":[59],"Many":[60],"therapies,":[62],"like":[63],"DNA-damaging":[64,122],"or":[66],"CDK4/6":[67,126,195],"inhibitors,":[68],"can":[69],"induce":[70,110,239],"senescence,":[71],"cellular":[73,83,240],"state":[74],"characterized":[75],"stable":[77],"cell-cycle":[78],"arrest.":[79],"Another":[80],"hallmark":[81],"of":[82,88,95,101,103,116,148,171,194,212],"senescence":[84,111,132,241],"enlargement":[87,130],"compartment.":[91],"Given":[92],"relevance":[94],"lysosome":[97],"mechanism":[100],"action":[102],"ADCs,":[104],"we":[105],"hypothesized":[106],"therapies":[108,220,237],"would":[112],"potentiate":[113],"efficacy":[115,246],"HER2-targeting":[117],"ADCs.":[118],"Treatment":[119],"with":[120,163,218,223,236],"agent":[123],"doxorubicin":[124],"inhibitor":[127,196],"induced":[128],"in":[133,174],"several":[134],"cancer":[136,188],"cell":[137],"lines.":[138],"While":[139],"senescence-inducing":[140,219],"drugs":[141],"did":[142],"not":[143],"increase":[144],"cytotoxic":[146],"target":[151],"cells,":[152],"was":[156],"enhanced":[157,176],"when":[158],"HER2-negative":[159],"were":[161],"cocultured":[162],"HER2-low":[164],"cells.":[165,255],"Knockdown":[166],"experiments":[167],"demonstrated":[168],"importance":[170],"cathepsin":[172,181],"B":[173,182],"effect,":[178],"suggesting":[179],"mediates":[183],"linker":[184],"cleavage.":[185],"In":[186],"patient-derived":[189],"xenografts,":[190],"combination":[192],"treatment":[193,205],"SYD985":[198],"showed":[199],"improved":[200],"effects":[202],"over":[203],"either":[204],"alone.":[206],"These":[207],"data":[208],"support":[209],"strategy":[211],"combining":[213],"next-generation":[214],"HER2":[217,227],"tumors":[222],"heterogenous":[224],"low":[226],"expression.":[228],"SIGNIFICANCE:":[229],"Combining":[230],"against":[232,252],"cancers":[235],"may":[242],"improve":[243],"their":[244],"therapeutic":[245],"facilitating":[248],"tumor":[254]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":19},{"year":2023,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-10-12T00:00:00"}